Canada Pension Plan Investment Board’s Amneal Pharmaceuticals AMRX Stock Holding History

Canada Pension Plan Investment Board’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-35,400	Closed	-$440K	–	1704
2026 Q1	$440K	Sell	35,400 -11,200	-24%	-$150K	﹤0.01%	1280
2025 Q4	$587K	Buy	46,600 +25,600	+122%	+$293K	﹤0.01%	1239
2025 Q3	$210K	Sell	21,000 -400	-2%	-$3.59K	﹤0.01%	1117
2025 Q2	$173K	Sell	21,400 -21,800	-50%	-$164K	﹤0.01%	1115
2025 Q1	$362K	Sell	43,200 -322,100	-88%	-$2.69M	﹤0.01%	994
2024 Q4	$2.89M	Buy	365,300 +8,300	+2%	+$69.6K	﹤0.01%	808
2024 Q3	$2.97M	Buy	357,000 +354,000	+11,800%	+$2.77M	﹤0.01%	802
2024 Q2	$19.1K	Buy	+3,000	New	+$19K	﹤0.01%	1328

Other funds holding AMRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Canada Pension Plan Investment Board's AMRX Position: Q2 2026 in Review

Canada Pension Plan Investment Board sold out of Amneal Pharmaceuticals (AMRX) in Q2 2026, closing a stake of 35,400 shares — an estimated $440K sold.

Canada Pension Plan Investment Board first reported a position in AMRX in Q2 2024 and held it in 8 quarters. The position peaked at $2.97M in Q3 2024. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

Canada Pension Plan Investment Board reported no remaining Amneal Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Canada Pension Plan Investment Board sold 35,400 Amneal Pharmaceuticals shares in Q2 2026, an estimated $440K.
Canada Pension Plan Investment Board first reported a position in Amneal Pharmaceuticals in Q2 2024 and held it in 8 quarters.
Canada Pension Plan Investment Board's Amneal Pharmaceuticals position peaked at $2.97M in Q3 2024.
311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.